DrugChatter | AI LLM Surveillance & Brand Protection for Pharma

AI Is Already Influencing Prescribing Decisions

Patients and clinicians are asking AI:

"Can this drug be used off-label?"

"What’s cheaper than this medication?"

"What’s the best treatment for X?"

And getting answers—often incomplete, outdated, or non-compliant.

You don’t control it. You can’t see it. You’re still responsible for it.

Off-Label Recommendations = Real Risk

When AI tools generate unapproved indications, incorrect dosing, or missing safety warnings, it creates exposure under frameworks enforced by the FDA and global regulators.

❌ Unapproved Indications
❌ Incorrect Dosing Instructions
❌ Omission of Black-Box Warnings

Key Regulatory Insight

"If AI consistently recommends your drug off-label and you have no documentation of monitoring or addressing the narrative, regulators may ask why you didn't act."

Diagram showing how AI synthesizes information from multiple sources, including clinical trials, prescriber forums, patient discussions, publications, and web content. The image illustrates that AI combines regulated and unregulated data to generate responses, which can lead to off-label recommendations without signaling uncertainty.

AI Doesn’t Follow Your Drug Label

Large language models don’t rely on a single source of truth. They synthesize answers from a wide range of inputs—often blending regulated and unregulated data.

📄 Clinical trials: Emerging and exploratory uses
🧑‍⚕️ Prescriber forums: Real-world off-label practices
💬 Patient discussions: Anecdotal outcomes and side effects
📚 Publications & abstracts: Early-stage evidence
🌐 Web content: Variable quality, often unverified

The result: AI can confidently generate answers that go beyond your approved label—without signaling uncertainty.

AI systems are designed to pull and combine information across sources to generate responses, rather than strictly adhering to a single controlled document.

If you’re not monitoring this, you’re not controlling your drug’s narrative.

Finally—Visibility Into AI-Generated Drug Narratives

We monitor, analyze, and classify what AI models say about your drug—continuously.

Prompt Surveillance

We simulate patient and physician queries across ChatGPT, Claude, and Gemini to build a living dataset of AI drug narratives.

Includes access to our bank of 1M+ actual user queries.

Off-Label Detection

Automatically classify on-label vs hallucinated claims using structured drug label intelligence (SPL data).

Model Drift Tracking

See how AI responses change over time as new clinical trial data or forum discussions enter the model ecosystem.

AI Share of Voice

A new industry metric: understand how often your drug is recommended vs competitors in efficacy benchmarks.

Real-Time Alerts

Get immediate notification when safety info is omitted or when a competitor's profile suddenly improves in LLM outputs.

Compliance Dashboard

Export-ready insights for Legal, Regulatory, and Pharmacovigilance teams to document monitoring efforts.

Designed for Teams That Can't Afford Blind Spots

Regulatory & Compliance

Identify off-label exposure early
Document rigorous monitoring efforts for auditors

Competitive Intelligence

Track how LLMs describe your drug vs competitors
Detect competitor-leaning bias in clinical logic
Benchmark "AI Share of Voice" metrics

Commercial Strategy

Track AI-driven shifts in brand perception
Identify new "digital KOL" narratives in LLM training data

Medical Affairs

Understand emerging use narratives
Detect scientific misinformation at scale

How It Works

Prompt Generation

We generate thousands of prompts across clinical scenarios.

Data Capture

AI responses are captured and structured in real-time.

Logic Analysis

Outputs are classified against official drug label data.

Intelligence Delivery

You get instant alerts, dashboards, and PDF reports.

End "Homebrewing"

Stop sales reps from using AI to create unapproved, non-compliant promotional copy. We audit internal usage to ensure collateral stays within the approved scientific dossier.

Misrepresentation Guard

Identify when LLMs are hallucinating your drug's efficacy or safety data. Protect your brand reputation from AI-driven misinformation across the web.

AE Signal Intelligence

Analyze the questions patients ask AI. We identify patterns that reveal previously unreported side effects or unmet patient needs in real-time.

What is AI Telling Your Patients About Your Drugs?

Monitor What AI Models Say About Your Drug—Before Regulators Do